Novel ADC Could Expand Treatment Options in Ovarian Cancer
(MedPage Today) -- Updated results from the FONTANA trial presented at the annual European Society for Medical Oncology congress showed promising activity with the investigational antibody-drug conjugate (ADC) torvutatug samrotecan (torvu-sam...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.